Antimicrobial peptides: Successes, challenges and unanswered questions

Journal of Membrane Biology

Volumn 239, Issue 1-2, 2011, Pages 27-34

  Wimley, William C ^a   Hristova, Kalina ^b  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Johns Hopkins University   (United States)

Author keywords

Antimicrobial peptide; Bacteria; Carpet model; Permeabilization

Indexed keywords

ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE;

ARTIFICIAL MEMBRANE; BIOLOGICAL MODEL; CELL WALL; DRUG EFFECT; LIPID BILAYER; REVIEW; SYNTHESIS;

ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CELL WALL; LIPID BILAYERS; MEMBRANES, ARTIFICIAL; MODELS, BIOLOGICAL;

EID: 79955669580     PISSN: 00222631     EISSN: 14321424     Source Type: Journal    
DOI: 10.1007/s00232-011-9343-0     Document Type: Article

References (48)

1. Almeida PF, Pokorny A (2009) Mechanisms of antimicrobial, cytolytic, and cell-penetrating peptides: from kinetics to thermodynamics. Biochemistry 48:8083-8093
2. Arias CA, Murray BE (2009) Antibiotic-resistant bugs in the 21st century-a clinical super-challenge. N Engl J Med 360:439-443
3. Bechinger B (2009) Rationalizing the membrane interactions of cationic amphipathic antimicrobial peptides by their molecular shape. Curr Opin Colloid Interface Sci 14:349-355
4. Bechinger B, Lohner K (2006) Detergent-like actions of linear amphipathic cationic antimicrobial peptides. Biochim Biophys Acta 1758:1529-1539 (Pubitemid 44436087)
5. Brahmachary M et al (2004) ANTIMIC: a database of antimicrobial sequences. Nucleic Acids Res 32(database issue D586-9):D586-D589
6. Cudic M, Otvos L Jr (2002) Intracellular targets of antibacterial peptides. Curr Drug Targets 3:101-106 (Pubitemid 34296201)
7. Demegen Pharmaceuticals (2010) Pharmaceutical products. Product profiles. Novel candidiasis therapy. www.demegen.com/pharma/candidiasis.htm
8. Easton DM et al (2009) Potential of immunomodulatory host defense peptides as novel anti-infectives. Trends Biotechnol 27:582-590
9. Epand RM, Epand RF (2009) Lipid domains in bacterial membranes and the action of antimicrobial agents. Biochim Biophys Acta 1788:289-294
10. Epand RF et al (2010) Probing the "charge cluster mechanism" in amphipathic helical cationic antimicrobial peptides. Biochemistry 49:4076-4084
11. Fjell CD, Hancock RE, Cherkasov A (2007) AMPer: a database and an automated discovery tool for antimicrobial peptides. Bioinformatics 23:1148-1155 (Pubitemid 47050567)
12. Gardy JL et al (2009) Enabling a systems biology approach to immunology: focus on innate immunity. Trends Immunol 30:249-262
13. Gazit E et al (1996) Structure and orientation of the mammalian antibacterial peptide cecropin P1 within phospholipid membranes. J Mol Biol 258:860-870 (Pubitemid 26150886)
14. Gregory SM et al (2008) A quantitative model for the all-or-none permeabilization of phospholipid vesicles by the antimicrobial peptide cecropin A. Biophys J 94:1667-1680
15. Gregory SM, Pokorny A, Almeida PF (2009) Magainin 2 revisited: a test of the quantitative model for the all-or-none permeabilization of phospholipid vesicles. Biophys J 96:116-131
16. Hamill P et al (2008) Novel anti-infectives: is host defence the answer? Curr Opin Biotechnol 19:628-636
17. Hancock RE, Sahl HG (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24:1551-1557 (Pubitemid 44967479)
18. He K et al (1996) Mechanism of alamethicin insertion into lipid bilayers. Biophys J 71:2669-2679 (Pubitemid 26367729)
19. Hong RW et al (2003) Transcriptional profile of the Escherichia coli response to the antimicrobial insect peptide cecropin A. Antimicrob Agents Chemother 47:1-6 (Pubitemid 36070334)
20. Hristova K, Selsted ME, White SH (1997) Critical role of lipid composition in membrane permeabilization by rabbit neutrophil defensins. J Biol Chem 272:24224-24233 (Pubitemid 27418623)
21. Huang HW, Chen FY, Lee MT (2004) Molecular mechanism of peptide-induced pores in membranes. Phys Rev Lett 92:198304
22. Kazemzadeh-Narbat M et al (2010) Antimicrobial peptides on calcium phosphate-coated titanium for the prevention of implant-associated infections. Biomaterials 31:9519-9526
23. Klein E, Smith DL, Laxminarayan R (2007) Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis 13:1840-1846 (Pubitemid 350248484)
24. Ladokhin AS, Selsted ME, White SH (1997) Sizing membrane pores in lipid vesicles by leakage of co-encapsulated markers: pore formation by melittin. Biophys J 72:1762-1766 (Pubitemid 27133115)
25. Ludtke SJ et al (1996) Membrane pores induced by magainin. Biochemistry 35:13723-13728 (Pubitemid 26363914)
26. Matsuzaki K, Yoneyama S, Miyajima K (1997) Pore formation and translocation of melittin. Biophys J 73:831-838 (Pubitemid 27337617)
27. Melo MN, Dugourd D, Castanho MA (2006) Omiganan penta-hydrochloride in the front line of clinical applications of antimicrobial peptides. Recent Pat Antiinfect Drug Discov 1:201-207
28. Merrifield RB, Vizioli LD, Boman HG (1982) Synthesis of the antibacterial peptide cecropin A (1-33). Biochemistry 21:5020-5031 (Pubitemid 13203097)
29. Ostolaza H et al (1993) Release of lipid vesicle contents by the bacterial protein toxin α-haemolysin. Biochim Biophys Acta 1147:81-88 (Pubitemid 23104891)
30. Otvos L Jr (2005) Antibacterial peptides and proteins with multiple cellular targets. J Pept Sci 11:697-706
31. Otvos L Jr et al (2006) Prior antibacterial peptide-mediated inhibition of protein folding in bacteria mutes resistance enzymes. Antimicrob Agents Chemother 50:3146-3149
32. Pittet D et al (2008) Infection control as a major World Health Organization priority for developing countries. J Hosp Infect 68:285-292
33. Pokorny A, Almeida PF (2004) Kinetics of dye efflux and lipid flip-flop induced by delta-lysin in phosphatidylcholine vesicles and the mechanism of graded release by amphipathic, alpha-helical peptides. Biochemistry 43:8846-8857 (Pubitemid 38880055)
34. Pokorny A et al (2008) The activity of the amphipathic peptide delta-lysin correlates with phospholipid acyl chain structure and bilayer elastic properties. Biophys J 95:4748-4755
35. Qian S et al (2008) Structure of the alamethicin pore reconstructed by X-ray diffraction analysis. Biophys J 94:3512-3522
36. Rapaport D, Shai Y (1991) Interaction of fluorescently labeled pardaxin and its analogues with lipid bilayers. J Biol Chem 266:23769-23775 (Pubitemid 21908863)
37. Rathinakumar R, Wimley WC (2008) Biomolecular engineering by combinatorial design and high-throughput screening: small, soluble peptides that permeabilize membranes. J Am Chem Soc 130:9849-9858
38. Rathinakumar R, Wimley WC (2010) High-throughput discovery of broad-spectrum peptide antibiotics. FASEB J 24:3232-3238
39. Rathinakumar R, Walkenhorst WF, Wimley WC (2009) Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity. J Am Chem Soc 131:7609-7617
40. Sengupta D et al (2008) Toroidal pores formed by antimicrobial peptides show significant disorder. Biochim Biophys Acta 1778:2308-2317
41. Shai Y (2002) Mode of action of membrane active antimicrobial peptides. Biopolymers 66:236-248
42. Steiner H et al (1981) Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature 292:246-248 (Pubitemid 11001840)
43. Wang Z, Wang G (2004) APD: the antimicrobial peptide database. Nucleic Acids Res 32:590-592
44. Westerhoff HV et al (1989) Magainins and the disruption of membrane-linked free-energy transduction. Proc Natl Acad Sci USA 86:6597-6601 (Pubitemid 19236322)
45. White SH, Wimley WC, Selsted ME (1995) Structure, function, and membrane integration of defensins. Curr Opin Struct Biol 5:521-527
46. Wimley WC (2010) Describing the mechanism of antimicrobial peptide action with the interfacial activity model. ACS Chem Biol 5:905-917
47. Yeaman MR, Yount NY (2003) Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev 55:27-55 (Pubitemid 36268398)
48. Yount NY, Yeaman MR (2004) Multidimensional signatures in antimicrobial peptides. Proc Natl Acad Sci USA 101:7363-7368 (Pubitemid 38638038)